C

Cannlabs Inc
OTC:CANL

Watchlist Manager
Cannlabs Inc
OTC:CANL
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $81.3k

Multiples-Based Value

CANL latest financial reports are more than 7 years old.
CANL doesn't have a meaningful market cap.

There is not enough data to reliably calculate the multiples-based value of CANL.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CANL Multiples-Based Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

CANL Competitors Multiples
Cannlabs Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Cannlabs Inc
OTC:CANL
81.3k USD 0 -0 -0.5 -0.5
US
CVS Health Corp
NYSE:CVS
100.1B USD 0.2 56.6 14.3 14.3
US
Cigna Group
XMUN:CGN
69.6B EUR 0.3 13.4 7.8 10
US
Cigna Corp
NYSE:CI
73.1B USD 0.3 12.3 0 0
DE
Fresenius SE & Co KGaA
XETRA:FRE
25.2B EUR 1.1 19.9 9.4 14.1
DE
Fresenius Medical Care AG
XMUN:FME
23.3B EUR 1.2 23.8 9.1 16.9
US
Laboratory Corporation of America Holdings
NYSE:LH
22.6B USD 1.6 25.7 12.3 17.8
US
Quest Diagnostics Inc
NYSE:DGX
21.9B USD 2 22.1 12 16.1
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.2B EUR 0.6 11.5 5.5 10.1
US
Guardant Health Inc
NASDAQ:GH
12.1B USD 12.4 -29.1 -31.8 -28.9
US
DaVita Inc
NYSE:DVA
10.2B USD 0.7 13.6 7.1 9.6
P/E Multiple
Earnings Growth PEG
US
C
Cannlabs Inc
OTC:CANL
Average P/E: 22.1
Negative Multiple: -0
N/A N/A
US
CVS Health Corp
NYSE:CVS
56.6
90%
0.6
US
C
Cigna Group
XMUN:CGN
13.4
19%
0.7
US
Cigna Corp
NYSE:CI
12.3
19%
0.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
19.9
26%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
23.8
16%
1.5
US
Laboratory Corporation of America Holdings
NYSE:LH
25.7
27%
1
US
Quest Diagnostics Inc
NYSE:DGX
22.1
12%
1.8
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.5
16%
0.7
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -29.1 N/A N/A
US
DaVita Inc
NYSE:DVA
13.6
20%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
C
Cannlabs Inc
OTC:CANL
Average EV/EBITDA: 9.7
Negative Multiple: -0.5
N/A N/A
US
CVS Health Corp
NYSE:CVS
14.3
28%
0.5
US
C
Cigna Group
XMUN:CGN
7.8
4%
2
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
DE
Fresenius SE & Co KGaA
XETRA:FRE
9.4
10%
0.9
DE
Fresenius Medical Care AG
XMUN:FME
9.1
7%
1.3
US
Laboratory Corporation of America Holdings
NYSE:LH
12.3
10%
1.2
US
Quest Diagnostics Inc
NYSE:DGX
12
6%
2
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
5.5
7%
0.8
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -31.8 N/A N/A
US
DaVita Inc
NYSE:DVA
7.1
4%
1.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
C
Cannlabs Inc
OTC:CANL
Average EV/EBIT: 13.6
Negative Multiple: -0.5
N/A N/A
US
CVS Health Corp
NYSE:CVS
14.3
22%
0.7
US
C
Cigna Group
XMUN:CGN
10
5%
2
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
DE
Fresenius SE & Co KGaA
XETRA:FRE
14.1
12%
1.2
DE
Fresenius Medical Care AG
XMUN:FME
16.9
11%
1.5
US
Laboratory Corporation of America Holdings
NYSE:LH
17.8
18%
1
US
Quest Diagnostics Inc
NYSE:DGX
16.1
9%
1.8
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.1
11%
0.9
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -28.9 N/A N/A
US
DaVita Inc
NYSE:DVA
9.6
5%
1.9
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett